Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3462 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Sareum Holdings and Genentech extend agreement

Under the terms of this agreement, Sareum will continue to apply its skills in high-throughput protein expression, purification and structure determination on drug discovery targets designated by Genentech.

FDA to review ProEthic’s migraine drug

PRO-513 is a patented formulation of diclofenac potassium powder for oral solution, which has been demonstrated to enhance the pharmacokinetic profile of diclofenac. This formulation is expected to

Abiomed to invest in WorldHeart

The loan is convertible, at Abiomed’s option, into common shares of WorldHeart at a conversion price of approximately $1.75 per share, resulting in an approximately 19.9% ownership interest

UCB files sNDA for CNS drug

The submission is based on two fixed-dose, randomized, double-blind, placebo-controlled efficacy and safety studies that evaluated rotigotine for the treatment of moderate-to-severe idiopathic restless legs syndrome (RLS) in